Healthcare -
Biotechnology - NASDAQ - US
$ 5.89
0.684 %
$ 252 M
Market Cap
-10.52
P/E
DMAC - RESEARCH & DEVELOPMENT
Research & Development DMAC - DiaMedica Therapeutics Inc.
13.1 M
LAST VALUE
22.30%
2 YEAR CAGR
23.72%
5 YEAR CAGR
13.24%
10 YEAR CAGR